|
|
 |
|
| News Release |
|
|
Information in the news releases is current on the date of the announcement, but is subject to change without prior notice. |
| 2003 Release |
|
| December 22, 2003 | |
Eisai Submits MAA for New Formulation of ARICEPT  (donepezil hydrochloride), Rapid Disintegration Tablet in the European Union
|
|
| December 18, 2003 | |
Eisai Submits NDAs for New Formulations of ARICEPT (donepezil hydrochloride), Rapid Disintegration Tablet and Liquid Formulation in the U.S.
|
|
| December 15, 2003 | |
Eisai Submits PARIET (rabeprazole sodium) for Zollinger-Ellison Syndrome and Other Pathological Hypersecretory Conditions in the European Union
|
|
| November 21, 2003 | |
Eisai Commences US Legal Action Over Aciphex ANDA Filings
|
|
| November 13, 2003 | |
Notice of Conclusion of License Agreement Regarding Research Information of Lung Cancer Gene
|
|
| November 10, 2003 | |
Eisai Launches Natural Vitamin E Capsule, JUVELUX E PURE
|
|
| November 5, 2003 | |
Notice Concerning Food Additives and Chemicals Division to be split off into a Newly Incorporated Subsidiary
|
|
| November 5, 2003 | |
Notice Concerning Dissolution of Subsidiary
|
|
| October 22, 2003 | |
Voluntary Product Recall of SKAINAR ANTITUSSIVE & EXPECTORANT
|
|
| September 24, 2003 | |
Toyama Chemical and Eisai Announce NDA submission to the Ministry of Health, Labour and Welfare
|
|
| September 18, 2003 | |
Eisai Launches SKAINAR S TABLETS FOR RHINITIS
Containing Pseudoephedrine Hydrochloride for Nasal Congestion
|
|
| September 16, 2003 | |
Eisai Submits Application for PARIET (rabeprazole sodium) for the On-Demand Therapy of Symptomatic GORD in the European Union
|
|
| September 12, 2003 | |
Eisai Launches MAXALT 10 mg Tablet, MAXALT RPD 10 mg Tablet , 5-HT1B/1D Receptor Agonist-Type Migraine Treatment Agents
|
|
| September 9, 2003 | |
Teva Pharmaceutical Industries Announces NDA Submission for Parkinson's Disease Treatment
|
|
| September 3, 2003 | |
Notice Concerning the Exemption from the Substitutional Portion of Eisai's Welfare Pension Fund
|
|
| August 19, 2003 | |
Eisai Launches NABOLINS, a Mecobalamin (Activated Vitamin B12) Tablet
|
|
| July 30, 2003 | |
Partial Amendment of the Marketing Alliance Agreement for the Migraine Treatment MAXALT
|
|
| July 30, 2003 | |
Food Additives and Chemicals Division to be placed into Subsidiary Company
|
|
| July 18, 2003 | |
PARIET 10 mg Receives Approval for Maintenance Therapy for Gastroesophageal Reflux Disease
|
|
| July 4, 2003 | |
Non-Approvable Letter Received from FDA for ARICEPT for VaD Treatment Indication
|
|
| July 1, 2003 | |
Notice Concerning Stock Options Including the Amount to Be Paid for the Exercise of Stock Options
|
|
| June 24, 2003 | |
Notice of Allotment of Stock Options
|
|
| June 23, 2003 | |
Eisai Launches Activated Vitamin B2 Tablet, CHOCOLABB PLUS
|
|
| May 26, 2003 | |
Eisai Submits sNDA for CLEACTOR for Acute Pulmonary Embolism
|
|
| May 15, 2003 | |
Teva and Eisai Sign Agreement for Co-Development of Rasagiline for Alzheimer's Disease, and Co-Promotion for Parkinson's Disease, in the U.S.
|
|
| May 13, 2003 | |
Notice on Providing Stock Options in the Form of New Stock Issuance
|
|
| May 13, 2003 | |
Notice Concerning Acquisition of the Company's Own Shares in the Market
|
|
| February 26, 2003 | |
Kyorin and Eisai Form an Alliance on Marketing of "rizatriptan benzoate" (generic name), an agent for migraine
|
|
| February 25, 2003 | |
Sanko Junyaku Co., Ltd., Eisai Co., Ltd. and FUJIREBIO INC. Conclude Joint Research Agreement for DCP Test Kit for Hepatocellular Carcinoma (HCC)
|
|
| February 24, 2003 | |
Eisai Co., Ltd. Establishes 'Neuroscience for Drug Discovery Research' Program at Kyoto University
|
|
| February 24, 2003 | |
CHOCOLAFE CARE, A 50ml Bottle Iron and Medicinal Herb Extract Drink
|
|
| February 6, 2003 | |
Eisai Co., Ltd. Starts SKAINAR Pollen Information Service
|
|
| February 3, 2003 | |
E7155, MRI Contrast Agent Application Withdrawn in Japan
|
|
| January 15, 2003 | |
Eisai Co., Ltd. and Mitsui Knowledge Industry Co., Ltd. Conclude Comprehensive Mutual Cooperation Agreement
|
|
| January 14, 2003 | |
Eisai Co., Ltd. Announces U.S. Subsidiary, Eisai Inc., to Increase Pharmaceutical Sales Force by 60 Percent
|
|
| January 7, 2003 | |
Eisai Inc., a U.S. Subsidiary of Eisai Co., Ltd. Assumes All Distribution Responsibilities for ARICEPT
|
|
| | | |
|
|
|
